J. Mark King

J. Mark King

59 year
Health Technology
Producer Manufacturing
Finance

Profile

J.
Mark King
is primarily engaged by the Firm to work with portfolio company leadership teams in the medical vertical to help them achieve strategic objectives and budgetary goals.
Mr. King will also support buy-side and sell-side processes for new medical device and components opportunities.
Prior to working with Vance Street in 2020, Mr. King held numerous executive leadership roles in the medical device market, both in branded product lines and in contract manufacturing.
Mr. King most recently served as President and Chief Executive Officer of Tegra Medical, a leading medical device contract manufacturer.
Prior to Tegra, Mr. King was President and Chief Executive Officer of Clinical Innovations, a market leader in women’s health medical devices.
In addition to Tegra Medical and Clinical Innovations, Mr. King has held leadership positions at Baxter Healthcare, Cardinal Health and Johnson and Johnson.
Mr. King holds a BS from the School of Technology at Purdue University and has completed Executive Education studies at the University of Wisconsin and Duke University.
Mr. King is a Six Sigma Green Belt.

Former positions of J. Mark King

CompaniesPositionEnd
Private Equity Investor 31/08/2022
Chief Executive Officer 31/07/2020
Chief Executive Officer 31/12/2011
SFS GROUP AG Chief Tech/Sci/R&D Officer -
Corporate Officer/Principal -
See the detail of J. Mark King's experience

Training of J. Mark King

Purdue University College of Science Undergraduate Degree

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of J. Mark King's experience

Connections

7

1st degree connections

6

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Listed companies1
SFS GROUP AG

Producer Manufacturing

Private companies4

Health Technology

Health Technology

Finance

Health Technology

See company connections